Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis Registry
Loriane Marina Michèle Verleye(Maastricht University Medical Centre), Tessa Straatmijer(Leiden University Medical Center), Martine van Workum, Zlatan Mujagic(Maastricht University Medical Centre), Myrthe R Naber(University Medical Center Utrecht), Nynke Boontje, Vince Biemans(Radboud University Nijmegen), Philip W. Voorneveld(Leiden University Medical Center), Steven Jeuring, Willemijn A. van Dop(Leiden University Medical Center), Loes H.C. Nissen(Radboud University Nijmegen), Bindia Jharap(Meander Medisch Centrum), Malena Schlotter, Marjolijn Duijvestein(Amsterdam University Medical Centers), Mark Lowenberg(Amsterdam Neuroscience), Marthe H. Verwey, Rachel West(Sint Franciscus Gasthuis), Herma H. Fidder(University Medical Center Utrecht), T. Römkens(Jeroen Bosch Ziekenhuis), Fiona D.M. van Schaik(University Medical Center Utrecht), Marijn C Visschedijk(University Medical Center Groningen), Alexander GL Bodelier(Amphia Ziekenhuis), Bas Oldenburg(University Medical Center Utrecht), Marieke J Pierik(Maastricht University Medical Centre), Dianne G; id_orcid 0000-0002-6208-2967 Bouwknegt(University Medical Center Groningen), Annemarie C de Vries(Erasmus MC), Lauranne AAP Derikx(Erasmus MC), Andrea E van der Meulen - de Jong(Leiden University Medical Center), Miranda Bouwens, Ilse Sour, Safioen Nabibaks, the Dutch Initiative on Crohn and Colitis (ICC), Anne Meyboom, Sandra Cosijns, Kyra Hermans, Ingrid Willemen-Boemaars, Jael Smid
Cited by 0
Related Papers
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
|Inflammatory Bowel Diseases|2010|199